Overview of Congenital Hepatic Fibrosis in Pediatrics: A Review

Congenital hepatic fibrosis is a rare developmental illness caused by a ductal plate malformation, often known as ciliopathy or fibrocystic liver disease. Hepatosplenomegaly and portal hypertension are two symptoms. The disease affects 1/10000–20000 people. frequently associated with a variety of illnesses caused by genetic abnormalities, such as autosomal recessive polycystic kidney disease (ARPKD) and Caroli syndrome. There hasn't been a way to stop or reverse the progression of congenital hepatic fibrosis until now. Clinical trials of anti-fibrotic medicines such as colchicine, interferon gamma, angiotensin II receptor blockers, pirfenidone, and ursodeoxycholic acid found no significant benefit. The only known cure for CHF is liver transplantation, which is recommended when the condition has progressed to the point when symptoms of liver failure have appeared. In this article we will be making overview of the disease. It’s symptoms and diagnosis, different treatment method, and we will compare some of the articles published about the disease.

[1]  R. Abilkassem,et al.  Congenital hepatic fibrosis: case report and review of literature , 2021, The Pan African medical journal.

[2]  Jiming Zhang,et al.  Congenital Hepatic Fibrosis in Children and Adults: Clinical Manifestations, Management, and Outcome—Case Series and Literature Review , 2020, Gastroenterology research and practice.

[3]  C. Koh,et al.  Noncirrhotic portal hypertension , 2018, Current opinion in gastroenterology.

[4]  I. Jankowska,et al.  Congenital hepatic fibrosis in a 9-year-old female patient – a case report , 2017, Clinical and experimental hepatology.

[5]  Ling Lin,et al.  Abernethy malformation associated with Caroli’s syndrome in a patient with a PKHD1 mutation: a case report , 2017, Diagnostic Pathology.

[6]  J. Emond,et al.  A Challenging Case of Hepatoblastoma Concomitant with Autosomal Recessive Polycystic Kidney Disease and Caroli Syndrome—Review of the Literature , 2017, Front. Pediatr..

[7]  S. Hamilton-Dutoit,et al.  Isolated congenital hepatic fibrosis associated with TMEM67 mutations: report of a new genotype–phenotype relationship , 2017, Clinical case reports.

[8]  R. Wells.  Hepatic fibrosis in children and adults , 2017, Clinical liver disease.

[9]  Xiaoli Du,et al.  [Clinical features of different clinical forms of childhood congenital hepatic fibrosis]. , 2016, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[10]  P. Rathi,et al.  A Family of Congenital Hepatic Fibrosis and Atypical Retinitis Pigmentosa , 2015, Clinics and Practice.

[11]  Y. Bayraktar,et al.  Novel variant syndrome associated with congenital hepatic fibrosis. , 2015, World journal of clinical cases.

[12]  N. Urgancı,et al.  Joubert syndrome and related disorders: a rare cause of intrahepatic portal hypertension in childhood. , 2015, European review for medical and pharmacological sciences.

[13]  V. Paradis,et al.  Congenital hepatic fibrosis with multiple HNF1α hepatocellular adenomas. , 2014, Clinics and research in hepatology and gastroenterology.

[14]  V. McLin,et al.  Liver involvement in children with ciliopathies. , 2014, Clinics and research in hepatology and gastroenterology.

[15]  W. Gahl,et al.  Congenital Hepatic Fibrosis Overview , 2014 .

[16]  P. Vajro,et al.  Management of adults with paediatric-onset chronic liver disease: strategic issues for transition care. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[17]  M. Goenka,et al.  Dealing with congenital hepatic fibrosis? Remember COACH syndrome , 2014, Clinical Journal of Gastroenterology.

[18]  D. Milford,et al.  Phenotypic Variation and Long-Term Outcome in Children With Congenital Hepatic Fibrosis , 2013, Journal of pediatric gastroenterology and nutrition.

[19]  B. Geramizadeh,et al.  Congenital Hepatic Fibrosis and Need for Liver Transplantation , 2010, International journal of organ transplantation medicine.

[20]  Y. Bayraktar,et al.  Experience of a single center with congenital hepatic fibrosis: a review of the literature. , 2010, World journal of gastroenterology.

[21]  Yasunori Sato,et al.  Recent progress in the etiopathogenesis of pediatric biliary disease, particularly Caroli's disease with congenital hepatic fibrosis and biliary atresia. , 2010, Histology and histopathology.

[22]  F. Brunello,et al.  AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers. , 2007, Journal of hepatology.

[23]  J. Armendáriz-Borunda,et al.  A pilot study in patients with established advanced liver fibrosis using pirfenidone , 2006, Gut.

[24]  M. Mourad,et al.  The place of liver transplantation in Caroli's disease and syndrome , 2006, Transplant international : official journal of the European Society for Organ Transplantation.

[25]  F. Alkuraya,et al.  Congenital hepatic fibrosis in a child with Prader-Willi syndrome: a novel association , 2014, Annals of Saudi medicine.